SynCardia Systems Growth, Revenue, Number of Employees and Funding

Overview

Location:
Tucson, AZ USA
Total Funding:N/A
Industry:Medical Equip
Founded:2001
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • SynCardia Systems's estimated revenue is currently $22.3M per year.
  • SynCardia Systems received $14.0M in venture funding in December 2013.
  • SynCardia Systems's estimated revenue per employee is $235147

Employee Data

  • SynCardia Systems has 95 Employees.
  • SynCardia Systems grew their employee count by 2% last year.
  • SynCardia Systems currently has 1 job openings.

Executive Contacts

NameTitle
Michael GarippaCEO/President
Brian BrogieVice President Manufacturing and Facilities
Karen StammDirector of Program Management
Steven LangfordVP Clincial Support
Judith SkrobackDirector of Clinical Research
Paul ZamanVice President Finance
Dena RichterVP Administration & Finance
Don WebberChief Executive Officer
Kerri HensleyDirector of Regulatory
Blago HerreraVice President Of Quality

What Is SynCardia Systems?

SynCardia Systems, LLC (www.syncardia.com) in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart (TAH) is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® Portable Driver, which powers the SynCardia TAH and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

keywords:Healthcare,Medical Devices,Pharmaceuticals

95

Number of Employees

$22.3M

Revenue (est)

1

Current Jobs

2%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
AdviNow Medical
$8M3417%$2.5M
Accelerate Diag...
$56.7M242-4%
SynCardia Syste...
$22.3M952%
Auer Precision ...
$8M346%
Life Care Solut...
$9M390%
Cranial Technol...
$66.3M28216%
WestPac Surgica...
$10.3M4426%

SynCardia Systems News

09/03/2019 - ESC 2019 – Carmat is stout-hearted in the face of a ...

Carmat claims that the only other total artificial heart currently on the market – Syncardia Systems' Total Artificial Heart – has a six-month ...

08/27/2019 - Artificial Heart Market 2019: Focusing on Top Leading ...

Top Key Vendors in Market: SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, ON-X LIFE TECHNOLOGIES ...

09/06/2019 - Cardiac Equipment Market 2019-2027 Development Status ...

Cardiac Equipment Market 2019-2027 Development Status with Future Vision – Thoratec Corporation, HeartWare Inc, SynCardia Systems, Inc, ...

SynCardia Systems Funding

DateAmountRoundLead InvestorsReference
2004-05-25$3.7MBArticle
2009-06-25$10.3MDHighway 12 VenturesArticle
2013-03-21$19.0MUndisclosedAthyrium Opportunities FundArticle
2013-12-18$14.0MUndisclosedWedbush PacGrow Life SciencesArticle

SynCardia Systems Executive Hires

DateNameTitleReference
2015-01-13Tim ShannonEVP Global Commercialization.Article
2015-02-25Dan HudspethCFOArticle
2017-03-15Brian Brogievp Manufacturing/FacilitiesArticle
2019-03-08Don WebberCEOArticle